Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis - Wikidata - wikimedia - TriplyDB

Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis

Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis

http://www.wikidata.org/entity/Q36984426

about

High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.Plasma brain natriuretic peptide levels are elevated in patients with cancer.Rheumatoid arthritis patients with active disease and no history of cardiac pathology have higher brain natriuretic peptide (BNP) levels than patients with inactive disease or healthy control subjects.Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis.Serum Levels of IL-6 and TNF-α May Correlate with Activity and Severity of Rheumatoid Arthritis.Association of epicardial adipose tissue with cardiometabolic risk and metabolic syndrome in patients with rheumatoid arthritis.Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR)Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation.Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.Magnetic Resonance Imaging-Detected Myocardial Inflammation and Fibrosis in Rheumatoid Arthritis: Associations With Disease Characteristics and N-Terminal Pro-Brain Natriuretic Peptide Levels.Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload.Brain natriuretic Peptide production and secretion in inflammation.Left ventricular morphology and function in patients with rheumatoid arthritis.Subclinical coronary artery disease in Asian rheumatoid arthritis patients who were in remission: a pilot study.Simple screening tools predict death and cardiovascular events in patients with rheumatic disease.Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.Subclinical left ventricular dysfunction in Behcet's disease assessed by two-dimensional speckle tracking echocardiography.Absence of Fibrosis and Inflammation by Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients with Low to Moderate Disease Activity.

P2860

Q28480869-A0EB4621-D0B2-464A-8D5D-9F0CE1DE49C1 Q33671233-656E7F9D-37DF-4B9B-AD9F-3D785864DFF6 Q33686973-BFAB0970-A4BD-429B-9E9C-0C9ED181C185 Q33751866-1074DA24-C82F-47FE-BC61-F5D2203E3ADA Q34357253-1990F9C2-9361-470A-91B0-CD96CDC2B4C8 Q34970160-3C9A125C-569A-4515-9890-EAC350C836B8 Q35019467-298684F3-327F-4B53-8EA9-80718E323B0B Q36412824-2CDE8956-8383-4D72-8A9E-B6B78A184A49 Q37179297-5DE13DFD-4C19-4BEF-9900-8C57BE986254 Q37292191-11EE4F26-E144-4612-8087-171564E29404 Q37658795-2FB97202-B053-438A-9537-0CF9EFEE109F Q37801768-2D388AF6-CE8A-442B-B24F-0E23B3FE17E6 Q38876331-A9C03151-0E72-4093-8491-F2E74D65CEBD Q39215532-A690114C-4436-45C2-87C0-F4F353FFF00D Q40700346-266B60EC-90E0-4CBF-B249-894A9F2AFD73 Q42392980-55C18B40-D840-4DFA-A883-59251611FF10 Q45265863-370D35F7-0885-4110-81E8-577647567913 Q48092063-0E5F07F2-98FB-4925-B4B5-D94A68F87D38 Q48152632-C9FD4FF6-9432-4E96-9B3E-CB4851989DFF Q48508157-5128B6D6-F5CD-4E6E-8BA3-1B9B47769469 Q49161866-EF7DDCE6-E9AC-47C2-8F75-853F50DFC00D Q52587395-CB31EFF9-DE44-47F9-BEDD-2F701ECE0960

P2860

Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis

http://www.wikidata.org/entity/Q36984426

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Amino-terminal fragment of the ...... eptide in rheumatoid arthritis

@en

type

label

Amino-terminal fragment of the ...... eptide in rheumatoid arthritis

@en

prefLabel

Amino-terminal fragment of the ...... eptide in rheumatoid arthritis

@en

P1433

Q36984426-E12236FA-A9C2-4A9B-8075-CC796EADF03D

P1476

Q36984426-EE23B71A-947A-4873-826B-AB67FC58B459

P2093

Q36984426-029FE550-C5EB-424F-839B-F94F2FE3427E

Q36984426-2818EEC3-3756-415B-9CCC-10610AE68E38

Q36984426-2DB7A2FE-5043-4904-8720-D8D35183780C

Q36984426-2F0AFFB8-1B9E-4046-9DEE-64B060FA6367

Q36984426-991C920F-1D30-4D91-A0BE-0EB35AE79E45

Q36984426-D2226017-C654-4272-99BE-6365D7ECCD77

Q36984426-D8944EE4-8C57-4E62-BB96-307BC28DAEA1

Q36984426-DE3E631C-712D-44E2-8DD9-E5D48768D45F

P2860

Q36984426-000A17C5-E145-4505-A097-67B7142222D9

Q36984426-125ECBCB-6189-4ADB-BEBF-6357BBA88650

Q36984426-1F2C4A0A-0FDC-49D7-8933-8C7AE21B6B15

Q36984426-27A0DFCC-8E9A-4977-B9A0-8DF059052724

Q36984426-280DD577-3849-4E19-959C-CF61D52E81B9

Q36984426-376AA5C6-32A2-4834-B4E5-B1D9E3E8F4D9

Q36984426-49CDAC29-C4D2-4A88-929C-A63AFDF91D2C

Q36984426-4AD50B81-AB07-4751-A9B9-3167A6F9FC59

Q36984426-5ED70127-AA94-477B-B884-DEB10730C68C

Q36984426-6573F42A-12A1-497E-9833-0BC821BA830F

P304

Q36984426-C293B1AB-EDC4-460C-98A5-589642F9A810

P31

Q36984426-6DFB429D-2B64-498C-989C-BFF9EA81EAA3

P356

Q36984426-1FB76D45-8BD3-49BB-9A3C-B316822F0B5C

P433

Q36984426-D69A2B8E-CD61-4EE7-BEEA-5FAA169DE32B

P478

Q36984426-6A03474E-EB38-41F4-A50B-D06B9C7733EE

P50

Q36984426-19A681A6-A9C3-43EE-A6AE-C1DF4762C0B5

Q36984426-1B62F960-9C90-44C7-863C-D4B9EFC20E1C

P577

Q36984426-5D290DA3-B728-4380-AE07-198B49A3F68F

P5875

Q36984426-21D2C5EF-36DC-4C25-B220-8CC658F8310C

P698

Q36984426-69D566C0-0E56-4840-87B8-6C0935F65095

P932

Q36984426-901BB39D-FB10-4972-BB51-CDC72DAF9607

P356

P1433

Arthritis & Rheumatology

P1476

Amino-terminal fragment of the ...... eptide in rheumatoid arthritis

@en

P2093

Annette Oeser

http://www.w3.org/2001/XMLSchema#string

Ayumi Shintani

http://www.w3.org/2001/XMLSchema#string

C Michael Stein

http://www.w3.org/2001/XMLSchema#string

Cecilia P Chung

http://www.w3.org/2001/XMLSchema#string

Ingrid Avalos

http://www.w3.org/2001/XMLSchema#string

Joseph Solus

http://www.w3.org/2001/XMLSchema#string

Paolo Raggi

http://www.w3.org/2001/XMLSchema#string

Tuulikki Sokka

http://www.w3.org/2001/XMLSchema#string

P2860

N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase

B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study.

Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

The mortality of rheumatoid arthritis.

Multiple biomarkers for the prediction of first major cardiovascular events and death.

Natriuretic peptides in the diagnosis and management of heart failure

Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.

P304

2662-2669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.23796

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Theodore Pincus

Tebeb Gebretsadik

P577

2008-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23225621

http://www.w3.org/2001/XMLSchema#string

P698

18759301

http://www.w3.org/2001/XMLSchema#string

P932

2587412

http://www.w3.org/2001/XMLSchema#string